Vaccine makers Pfizer and Moderna pledge massive boost to U.S. supply after sluggish rollout

by

The increases needed to meet March delivery targets will be steep, however, and Biden administration officials expect the companies could come up slightly short.

View original article
Contributor: Isaac Stanley-Becker